Showing results (331-340 of 376) with videos related to
Sort By:
Pageof 38
International Journal of Pharmaceutics|February 4, 2023
Bacteriophage endolysin powders for inhaled delivery against pulmonary infectionsYuncheng Wang, Dipesh Khanal, Adit B Alreja, et al.Antimicrobial Agents and Chemotherapy|July 6, 2021
Polymyxin-Induced Metabolic Perturbations in Human Lung Epithelial CellsMaizbha U Ahmed, Mohammad A K Azad, Mengyao Li, et al.Molecular Pharmaceutics|September 21, 2017
Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of CryptosporidiosisYingyue Zhang, Jie Feng, Simon A McManus, et al.International Journal of Pharmaceutics|July 20, 2017
Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancerMichael Y T Chow, Yingshan Qiu, Fiona F K Lo, et al.Journal of Aerosol Medicine and Pulmonary Drug Delivery|November 12, 2020
Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19Ahmed H Albariqi, Rachel Yoon Kyung Chang, Waiting Tai, et al.Antibiotics (Basel, Switzerland)|March 25, 2022
Polymyxin Induces Significant Transcriptomic Perturbations of Cellular Signalling Networks in Human Lung Epithelial CellsMengyao Li, Mohammad A K Azad, Maizbha U Ahmed, et al.International Journal of Pharmaceutics|July 7, 2026
In situ characterization of aerosol deposition in dry powder inhalers using optical coherence tomographyTaye Tolu Mekonnen, Liam Milton-McGurk, Waiting Tai, et al.The AAPS Journal|November 26, 2015
Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and RifampicinWenbo Wang, Qi Tony Zhou, Si-Ping Sun, et al.Antimicrobial Agents and Chemotherapy|April 19, 2017
Potential Toxicity of Polymyxins in Human Lung Epithelial CellsMaizbha U Ahmed, Tony Velkov, Yu-Wei Lin, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 5, 2022
The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in miceRachel Yoon Kyung Chang, Michael Y T Chow, Yuncheng Wang, et al.Pageof 38